Prior authorization (PA) is a time-consuming and costly burden on healthcare providers. With an increase in specialty medication spending, accounting for 70% of total drug spend, PAs are expected to become more stringent and restrictive. Marylou Buyse and Charline Shan share their insight and explore how the vertical integration mergers might impact PA for the better.
A new study by Senior Director, Policy & Economics Julia Thornton Snider, PhD, was recently published in the medical journal Vaccine. (more…)
Challenges persist in measuring value in healthcare, and individual healthcare decision makers need personalized information about value to make informed choices. Precision’s Mark Linthicum, Jennifer Bright, and Jason Shafrin explore an open-source modeling approach to value assessment in an article for Journal of Clinical Pathways.
PHE Senior Research Economist James Baumgardner, PhD, and colleagues conducted an analysis aimed at determining whether spending within oncology care episodes is associated with survival. (more…)
As a guest contributor to Clinical Leader, Precision for Value’s Dominic Galante examines the importance of payer perspective during clinical R&D. With a greater push for evidence-based value, scientists are starting to incorporate payer insights earlier in drug development.
The Bipartisan Budget Act of 2018 (BBA 2018) directly affects Medicare Part D drugs, but its impact could expand beyond. Precision for Value’s Joanne Mai and Andrew Cournoyer cover how this change in the Medicare coverage gap program represents a small step toward encouraging biosimilar development, containing drug prices, and improving patient access. (more…)
In the Journal of Clinical Pathways our experts identify key factors influencing the implementation of value-based contracting. (more…)
As the US healthcare landscape continues to change at a rapid rate, Kellie Rademacher and Jeremy Schafer take a closer look at the emerging trend of vertical integration. (more…)
In an article in Managed Care, Jeremy Schafer discusses the findings from a recent breast cancer study reported in JAMA. (more…)
Led by a team of PHE researchers, a new study appearing in the American Journal of Managed Carehas determined that long-term cancer survivors can expect health and quality of life on par with Americans of the same age and background. (more…)